Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis

BACKGROUND: Warfarin is commonly used as a secondary prevention of stroke in patients with atrial fibrillation (AF). However, limitations have been observed even with the use of this medication. Recently, several newer direct oral anticoagulants (DOACs) have been approved for use by the food and dru...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cardiovasc Disord
Main Authors: Bundhun, Pravesh Kumar, Soogund, Mohammad Zafooruddin Sani, Teeluck, Abhishek Rishikesh, Pursun, Manish, Bhurtu, Akash, Huang, Wei-Qiang
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216587/
https://ncbi.nlm.nih.gov/pubmed/28056795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-016-0449-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados